Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Capsule Retentions and Incomplete Capsule Endoscopy Examinations: An Analysis of 2300 Examinations
- C. Höög, Lars-Åke Bark, Juan Arkani, J. Gorsetman, O. Broström, U. Sjöqvist
- Medicine
- Gastroenterology research and practice
- 29 September 2011
Aim. To evaluate capsule endoscopy in terms of incomplete examinations and capsule retentions and to find risk factors for these events. Material and Methods. This retrospective and consecutive study… Expand
Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn’s disease
- C. Höög, Lars-Åke Bark, O. Broström, U. Sjöqvist
- Medicine
- Scandinavian journal of gastroenterology
- 20 August 2014
Abstract Objective. Capsule endoscopy (CE) is a sensitive method for detecting inflammatory lesions in the small bowel. Such lesions may be due to Crohn’s disease but also to other causes and a… Expand
High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth…
- J. Dahlerup, B. Jacobsen, J. C. van der Woude, Lars-Åke Bark, L. Thomsen, S. Lindgren
- Medicine
- Scandinavian journal of gastroenterology
- 21 June 2016
Abstract Objective: Iron isomaltoside (Monofer®) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency… Expand
M1707 One Hour Infliximab Infusion Can Replace Two Hour Infusion in Maintenance Treatment of Crohns Disease Without Shortcomings, in Patients Treated for Up to Three Years
- R. Befrits, L. Malmström, Anette Forsell, Lars-Åke Bark, L. Blomquist
- Medicine
- 1 April 2008
Tolerability of Shortened Infliximab Infusion in Scheduled Maintenance Therapy for IBD: A Prospective Multi-center European Cohort Study
- R. Befrits, Annika Olsson, +11 authors G. Assche
- Medicine
- 21 June 2013
AIM: Although an infusion time of at least one hour is mandated by the European label for infliximab (IFX) maintenance treatment of patients with IBD, shorter infusion times of 30 minutes have been… Expand